ESOPHAGEAL SQUAMOUS CELL CARCINOMAS
Clinical trials for ESOPHAGEAL SQUAMOUS CELL CARCINOMAS explained in plain language.
Never miss a new study
Get alerted when new ESOPHAGEAL SQUAMOUS CELL CARCINOMAS trials appear
Sign up with your email to follow new studies for ESOPHAGEAL SQUAMOUS CELL CARCINOMAS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New combo therapy shows promise for tough esophageal cancer
Disease control OngoingThis study tests a new treatment plan for people with advanced esophageal cancer that cannot be surgically removed. Participants first receive immunotherapy plus chemotherapy, followed by chemoradiation. The goal is to see if this approach improves survival and controls the disea…
Matched conditions: ESOPHAGEAL SQUAMOUS CELL CARCINOMAS
Phase: PHASE2 • Sponsor: Shanghai Chest Hospital • Aim: Disease control
Last updated Jun 27, 2026 09:01 UTC
-
New hope for hard-to-treat esophageal cancer?
Disease control OngoingThis study tests a combination of two drugs, SI-B001 and irinotecan, in people with advanced esophageal cancer that has come back or spread. The goal is to see if the combo can shrink tumors and control the disease. About 22 adults who have already tried standard treatments are t…
Matched conditions: ESOPHAGEAL SQUAMOUS CELL CARCINOMAS
Phase: PHASE2 • Sponsor: Sichuan Baili Pharmaceutical Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 07:51 UTC